High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from? ; volume:17 ; number:1 ; day:6 ; month:1 ; year:2017 ; pages:1-10 ; date:12.2017
BMC infectious diseases ; 17, Heft 1 (6.1.2017), 1-10, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Ragonnet, Romain
- Beteiligte Personen und Organisationen
-
Trauer, James M.
Denholm, Justin T.
Marais, Ben J.
McBryde, Emma S.
SpringerLink (Online service)
- DOI
-
10.1186/s12879-016-2171-1
- URN
-
urn:nbn:de:1111-201702024289
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ragonnet, Romain
- Trauer, James M.
- Denholm, Justin T.
- Marais, Ben J.
- McBryde, Emma S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multidrug-resistant tuberculosis
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
Nomogram to predict multidrug-resistant tuberculosis
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Efficient Photolysis of Multidrug‐Resistant Polymicrobial Biofilms
Nanocatalytic materials against multidrug-resistant bacterial infection
Characteristics of multidrug-resistant tuberculosis in Namibia
Multidrug-resistant Mycoplasma genitalium infections in Europe
Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
Multidrug-resistant tuberculosis
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
Nomogram to predict multidrug-resistant tuberculosis
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Efficient Photolysis of Multidrug‐Resistant Polymicrobial Biofilms
Nanocatalytic materials against multidrug-resistant bacterial infection
Characteristics of multidrug-resistant tuberculosis in Namibia
Multidrug-resistant Mycoplasma genitalium infections in Europe
Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
Multidrug-resistant tuberculosis
Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
Nomogram to predict multidrug-resistant tuberculosis
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Efficient Photolysis of Multidrug‐Resistant Polymicrobial Biofilms
Nanocatalytic materials against multidrug-resistant bacterial infection
Characteristics of multidrug-resistant tuberculosis in Namibia
Multidrug-resistant Mycoplasma genitalium infections in Europe
Overcoming Multidrug‐Resistant MRSA Using Conventional Aminoglycoside Antibiotics
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa